ClinicalTrials.Veeva

Menu

Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy (STING)

K

Kliniken Ludwigsburg-Bietigheim gGmbH

Status

Unknown

Conditions

Acute Upper Gastrointestinal Hemorrhage

Treatments

Device: Endoscopic hemostasis

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Prospective-randomized trial. Patients with recurrent bleeding from gastroduodenal ulcers are randomized into either endoscopic treatment with the OTSC [Over The Scope Clip] or endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to standard therapy regarding technical success and rebleeding.

Enrollment

64 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Recurrence of bleeding from gastroduodenal ulcers

Exclusion criteria

  • Malignant ulcers, variceal bleeding, patients younger than 18 years, lesions not suitable for treatment with OTSC

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Standard Therapy
Active Comparator group
Description:
Endoscopic therapy with Standard Clip + injection of epinephrine solution or thermal therapy + injection of epinephrin-solution
Treatment:
Device: Endoscopic hemostasis
OTSC (Over The Scope Clip)
Experimental group
Description:
Endoscopic therapy with Application of OTSC Clip and Injection of epinephrin-solution
Treatment:
Device: Endoscopic hemostasis

Trial contacts and locations

1

Loading...

Central trial contact

Arthur Schmidt, Dr.; Karel Caca, Prof. Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems